GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii

Parasite Immunology

Volumn 29, Issue 9, 2007, Pages 445-453

  Jongert, E ^a   De Craeye, S ^a   Dewit, J ^a   Huygen, K ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

Author keywords

Cocktail DNA vaccine; GRA1; GRA7; Interferon ; Protection; ROP2; Toxoplasma gondii

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; PROTEIN GRA1; PROTEIN GRA7; PROTEIN ROP2; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; FEMALE; INTERFERON TYPE II; MEMBRANE PROTEINS; MICE; MICE, INBRED C3H; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

MUS; TOXOPLASMA GONDII;

EID: 34548154931     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2007.00961.x     Document Type: Article

References (42)

1. Montoya JG Liesenfeld O. Toxoplasmosis. Lancet 2004 363 : 1965 1976.
2. Denkers EY Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998 11 : 569 588.
3. Yap GS Sher A. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Immunobiology 1999 201 : 240 247.
4. Gilbert R, Tan HK, Cliffe S, Guy E Stanford M. Symptomatic toxoplasma infection due to congenital and postnatally acquired infection. Arch Dis Child 2006 91 : 495 498.
5. Tenter AM, Heckeroth AR Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000 30 : 1217 1258.
6. Aspinall TV, Marlee D, Hyde JE Sims PF. Prevalence of Toxoplasma gondii in commercial meat products as monitored by polymerase chain reaction - food for thought? Int J Parasitol 2002 32 : 1193 1199.
7. Kijlstra A, Eissen OA, Cornelissen J, Munniksma K, Eijck I Kortbeek T. Toxoplasma gondii infection in animal-friendly pig production systems. Invest Ophthalmol Vis Sci 2004 45 : 3165 3169.
8. Cook AJ, Gilbert RE, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000 321 : 142 147.
9. Angus CW, Klivington-Evans D, Dubey JP Kovacs JA. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000 181 : 317 324.
10. Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003 21 : 2813 2820.
11. Scorza T, D'Souza S, Laloup M, et al. A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection. Infect Immun 2003 71 : 309 316.
12. Vercammen M, Scorza T, Huygen K, et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000 68 : 38 45.
13. Desolme B, Mevelec MN, Buzoni-Gatel D Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000 18 : 2512 2521.
14. Guo H, Chen G, Lu F, Chen H Zheng H. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-γ against Toxoplasma gondii in mice. Chin Med J (Engl) 2001 114 : 317 320.
15. Leyva R, Herion P Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res 2001 87 : 70 79.
16. Ismael AB, Sekkai D, Collin C, Bout D Mevelec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003 71 : 6222 6228.
17. Fatoohi AF, Cozon GJ, Greenland T, et al. Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clin Diagn Lab Immunol 2002 9 : 704 707.
18. Jacquet A, Daminet V, Haumont M, et al. Expression of a recombinant Toxoplasma gondii ROP2 fragment as a fusion protein in bacteria circumvents insolubility and proteolytic degradation. Protein Expr Purif 1999 17 : 392 400.
19. Saavedra R, Becerril MA, Dubeaux C, et al. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii. Infect Immun 1996 64 : 3858 3862.
20. Beghetto E, Pucci A, Minenkova O, et al. Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. Int J Parasitol 2001 31 : 1659 1668.
21. Jacobs D, Vercammen M Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 1999 6 : 24 29.
22. van Gelder P, Bosman F, de Meuter F, van Heuverswyn H Herion P. Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli. J Clin Microbiol 1993 31 : 9 15.
23. + T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. J Immunol 1992 148 : 1493 1498.
24. + cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. J Immunol 1991 147 : 3955 3959.
25. + T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect Immun 1996 64 : 176 181.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 2001 29 : e45.
27. Bivas-Benita M, Laloup M, Versteyhe S, et al. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharm 2003 266 : 17 27.
28. Nigro M, Gutierrez A, Hoffer AM, et al. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn Microbiol Infect Dis 2003 47 : 609 613.
29. Nigro M, Martin V, Kaufer F, Carral L, Angel SO Pszenny V. High level of expression of the Toxoplasma gondii-recombinant Rop2 protein in Escherichia coli as a soluble form for optimal use in diagnosis. Mol Biotechnol 2001 18 : 269 273.
30. Romano M, Denis O, D'Souza S, et al. Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis. J Immunol 2004 172 : 6913 6921.
31. Sedegah M, Charoenvit Y, Minh L, et al. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther 2004 11 : 448 456.
32. Sedegah M, Charoenvit Y, Aguiar J, et al. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun 2004 5 : 553 561.
33. Iborra S, Soto M, Carrion J, Alonso C Requena JM. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis. Vaccine 2004 22 : 3865 3876.
34. Mishima M, Xuan X, Yokoyama N, et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol Res 2002 88 : 144 149.
35. Neudeck A, Stachelhaus S, Nischik N, Striepen B, Reichmann G Fischer HG. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect 2002 4 : 581 590.
36. Beghetto E, Nielsen HV, Del Porto P, et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J Infect Dis 2005 191 : 637 645.
37. Nielsen HV, Di Cristina M, Beghetto E, Spadoni A, Petersen E Gargano N. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Exp Parasitol 2006 112 : 274 279.
38. Fachado A, Rodriguez A, Angel SO, et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003 21 : 1327 1335.
39. Mevelec MN, Bout D, Desolme B, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005 23 : 4489 4499.
40. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991 146 : 286 292.
41. Suzuki Y, Orellana MA, Schreiber RD Remington JS. Interferon-γ: the major mediator of resistance against Toxoplasma gondii. Science 1988 240 : 516 518.
42. Gazzinelli RT, Wysocka M, Hayashi S, et al. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994 153 : 2533 2543.